Breaking News, Business, Financial and Economic News, World News from EconoTimes

Become a contributor

Bookmark Econotimes

Tue, Apr 29, 2025 03:40 AM All times are UTC

Follow Series

©Econometrics LLC 2025. All Rights Reserved.

Nauro Campos

Nauro Campos is Professor of Economics and Finance at Brunel University London, a post he has held since 2005. He is also a Research Fellow at IZA-Bonn and a Research Professor at ETH-Zürich. His main fields of interest are political economy and European integration. He has previously taught at the Universities of Bonn, CERGE-EI (Prague), Newcastle, Paris 1 (Sorbonne) and Warwick. He was a Fulbright Fellow at Johns Hopkins University (Baltimore), a Robert McNamara Fellow at The World Bank, and a CBS Fellow at Oxford University. He is a member of the Scientific Advisory Board of the (Central) Bank of Finland and was a visiting scholar (usually more than once) at the IMF, World Bank, European Commission, University of Michigan, ETH, USC, Bonn, UCL and Stockholm. From 2009 to 2014, he was seconded as Senior Economic Advisor/SRF to the Chief Economist of the Department for International Development (during the reigns of both Winters and Dercon.) He received his Ph.D. from the University of Southern California (Los Angeles) in 1997, where he was lucky enough to learn about institutions from Jeff Nugent and Jim Robinson and (more than) happy to be Dick Easterlin’s RA for three years. His research has been supported, among others, by the European Commission, World Bank, Spencer Foundation (Chicago), Department for International Development, and the Economic and Social Research Council.

Briferendum Aftermath Series

Brexit: 100 days on ... and where's the economic Armageddon?

Sep 30, 2016 12:34 pm UTC| Insights & Views Economy

Most economists argued against Brexit. Actually, pretty much every single economist argued against Brexit except the eight Economists for Brexit. This extraordinary near consensus emerged because a full range of models,...

Briferendum Series

Do the Treasury's Brexit numbers add up?

Apr 20, 2016 11:08 am UTC| Insights & Views

If we take as a central assumption that the UK would seek a negotiated bilateral agreement, like Canada has, the costs to Britain are clear. Based on the Treasurys estimates, our GDP would be 6.2% lower, families would be...

Economy

South Korea’s Exports Expected to Drop in April Amid U.S. Tariff Pressures

South Koreas exports likely declined in April for the first time in three months, hit by escalating U.S. tariffs under President Donald Trump, according to a Reuters survey. Economists polled between April 23-28 forecast a...

Crude Oil Prices Dip as U.S.-China Trade Tensions Weigh on Demand Outlook

Crude oil prices slipped in early Asian trading Tuesday, pressured by weaker demand expectations amid escalating trade tensions between the United States and Chinathe worlds largest oil consumers. Brent crude futures...

Dollar Struggles Amid Trade War Confusion and Weakening U.S. Outlook

The dollar struggled to recover on Tuesday after sharp losses, as confusion over the Sino-U.S. trade war continued to unsettle markets. Treasury Secretary Scott Bessent said the onus was on China to de-escalate tariffs,...

U.S. Stocks Edge Higher as Investors Focus on Trade Hopes, Earnings Reports

U.S. stocks posted modest moves on Monday as investors digested trade updates and awaited key earnings reports. The Dow Jones Industrial Average rose 114 points, or 0.28%, while the SP 500 inched up 3 points, or 0.06%. The...

Japan and Vietnam Strengthen Trade Ties Amid U.S. Tariff Tensions

Japan and Vietnam agreed to deepen bilateral trade and uphold global trade rules as Japanese Prime Minister Shigeru Ishiba met with Vietnamese leaders in Hanoi on Monday. The meeting comes as both nations negotiate with...

Politics

Zelenskiy Praises Ukraine's Intelligence Amid Russian Officer Deaths

Ukrainian President Volodymyr Zelenskiy on Monday commended Ukraines foreign intelligence agency for eliminating top Russian military officials since the war began, without directly addressing the recent car bomb killing...

Pakistan Warns of Imminent Indian Attack Amid Kashmir Tensions

Pakistans Defence Minister Khawaja Muhammad Asif warned Monday that a military incursion by India could happen soon following a deadly militant attack in Kashmir that killed 26 tourists. The attack has sparked outrage in...

Mark Carney's Liberals Win Canadian Election but Fall Short of Majority

Canadian Prime Minister Mark Carneys Liberal Party won the national election on Monday but is projected to fall short of a majority, according to CTV News. Liberals secured 156 seats, while 172 are needed for a majority in...

Iran Proposes Rome Talks with Europe Amid Renewed U.S. Nuclear Negotiations

Iran has proposed a meeting with Britain, France, and Germany (E3) in Rome this Friday to advance discussions on the 2015 nuclear deal, diplomats said Monday. The proposal follows renewed nuclear negotiations between...

Trump Appoints Ha Nguyen McNeill as Acting TSA Head Amid Union Dispute

Former White House official Ha Nguyen McNeill has been appointed as the acting head of the Transportation Security Administration (TSA), the agency announced Monday. McNeill, who previously served as TSAs chief of staff...

Science

Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global...

AstraZeneca’s Imfinzi Gets US Approval for Bladder Cancer Treatment

AstraZenecas drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder cancer, a significant advancement in cancer therapy. The approval allows Imfinzi to be used in...

Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing

The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY). Designed for patients aged 12 and older with hemophilia A or B,...

FDA Vaccine Chief Peter Marks Resigns Amid Controversy Over Transparency

Peter Marks, the U.S. Food and Drug Administrations (FDA) top vaccine official, has resigned after reportedly being forced out by the Department of Health and Human Services (HHS), according to The Wall Street Journal....

Museums have tons of data, and AI could make it more accessible − but standardizing and organizing it across fields won’t be easy

Ice cores in freezers, dinosaurs on display, fish in jars, birds in boxes, human remains and ancient artifacts from long gone civilizations that few people ever see museum collections are filled with all this and more....

Technology

Alibaba Launches Qwen 3 AI Model Amid Intensifying China Tech Competition

Chinese tech giant Alibaba Group (NYSE:BABA) unveiled Qwen 3 on Tuesday, a next-generation AI model featuring hybrid reasoning capabilities aimed at boosting performance and adaptability. The move underscores Alibabas...

Amazon Enters Satellite Internet Race with First Kuiper Deployment

Amazon (NASDAQ:AMZN) has officially entered the satellite broadband market with the successful launch of 27 operational satellites for Project Kuiper, its high-speed internet initiative aimed at rivaling SpaceXs Starlink....

Chinese AI App DeepSeek Resumes Downloads in South Korea After Privacy Update

Chinese artificial intelligence app DeepSeek has resumed availability in South Koreas app stores after a two-month suspension due to data protection concerns. Downloads were halted in February when South Koreas Personal...

Nvidia Shares Dip as Huawei Tests Rival AI Chip

Nvidia Corporation (NASDAQ: NVDA) slipped in after-hours trading on Sunday, following reports that Chinas Huawei is testing a powerful artificial intelligence chip aimed at challenging Nvidias dominance. NVDA shares fell...

Huawei Challenges Nvidia with New Ascend 910D AI Chip Amid U.S. Export Curbs

Huawei Technologies is preparing to launch its most advanced artificial intelligence processor yet, the Ascend 910D, aiming to compete with Nvidias high-end chips, according to a Wall Street Journal report. Sample batches...